Carol Nasr, MD
Rheumatology · Morristown, NJNPI 1154827277
Payments from drug & device makers
Across 183 payments — averaging $17.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$658
- AbbVie$593
- Amgen$473
- Novartis$378
- Pfizer$278
- GSK$183
- plus $717 from 16 others
What the payments were for
- Food & beverage$3,04693%
- Education$2347%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 27 | $658 |
| AbbVie | 39 | $593 |
| Amgen | 33 | $473 |
| Novartis | 20 | $378 |
| Pfizer | 16 | $278 |
| GSK | 10 | $183 |
| UCB, Inc. | 8 | $146 |
| Sobi, Inc | 3 | $123 |
| ANI Pharmaceuticals, Inc. | 5 | $82 |
| E.r. Squibb & Sons, L.L.C. | 5 | $78 |
| Lilly USA, LLC | 3 | $51 |
| Aurinia Pharma U.S., Inc. | 2 | $36 |
| Fresenius Kabi USA, LLC | 2 | $30 |
| Organon | 2 | $30 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Calliditas Therapeutics US Inc. | 1 | $19 |
| Grifols USA, LLC | 1 | $17 |
| AstraZeneca | 1 | $17 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $16 |
| Cormedix Inc. | 1 | $16 |
| Almatica Pharma LLC | 1 | $15 |
How this compares
$3,280 in reported general payments places this provider in the 50th percentile of 234 rheumatology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Teriparatide | 13 | $39,536 |
| MethotrexateMethotrexate Sodium | 86 | $1,712 |
| Hydroxychloroquine Sulfate | 41 | $1,480 |
| Prednisone | 101 | $1,268 |
| Celecoxib | 14 | $1,081 |
| Diclofenac Sodium | 19 | $704 |
| Colchicine | 11 | $409 |
| Alendronate Sodium | 19 | $360 |
| Gabapentin | 22 | $239 |
| Pantoprazole Sodium | 17 | $192 |
| Methylprednisolone | 26 | $163 |
| Allopurinol | 30 | $150 |
| Famotidine | 11 | $69 |
| Meloxicam | 27 | $22 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Morristown
- Mark TratenbergMorristown$23K
- Joshua LiuMorristown$9K
- Neil KramerSummit$1.8M
- Lori CoxNew Brunswick$1.4M
- Joshua SundharVoorhees$1.3M
- Richard HaddadRed Bank$1.1M
- Kiren SahniWest Long Branch$730K
- Ramesh KumarToms River$504K
- Hisham El KadiFreehold$480K
- Jeffrey GreenbergSummit$451K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.